Compare Suven Life Sciences with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES J.B.CHEMICALS SUVEN LIFE SCIENCES/
J.B.CHEMICALS
 
P/E (TTM) x -86.3 38.5 - View Chart
P/BV x 1.4 7.2 18.9% View Chart
Dividend Yield % 1.7 0.2 1,032.1%  

Financials

 SUVEN LIFE SCIENCES   J.B.CHEMICALS
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
J.B.CHEMICALS
Mar-18
SUVEN LIFE SCIENCES/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs338363 93.0%   
Low Rs169255 66.4%   
Sales per share (Unadj.) Rs52.1169.1 30.8%  
Earnings per share (Unadj.) Rs6.816.6 41.2%  
Cash flow per share (Unadj.) Rs8.623.4 36.6%  
Dividends per share (Unadj.) Rs1.502.00 75.0%  
Dividend yield (eoy) %0.60.6 91.4%  
Book value per share (Unadj.) Rs65.3172.5 37.8%  
Shares outstanding (eoy) m127.2883.57 152.3%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.91.8 266.2%   
Avg P/E ratio x37.118.6 199.4%  
P/CF ratio (eoy) x29.613.2 224.2%  
Price / Book Value ratio x3.91.8 216.8%  
Dividend payout %22.012.0 182.3%   
Avg Mkt Cap Rs m32,27225,827 125.0%   
No. of employees `0001.13.8 28.7%   
Total wages/salary Rs m6612,511 26.3%   
Avg. sales/employee Rs Th6,132.23,747.4 163.6%   
Avg. wages/employee Rs Th611.1665.7 91.8%   
Avg. net profit/employee Rs Th803.5367.8 218.5%   
INCOME DATA
Net Sales Rs m6,63514,135 46.9%  
Other income Rs m242366 66.2%   
Total revenues Rs m6,87714,501 47.4%   
Gross profit Rs m1,6042,178 73.6%  
Depreciation Rs m221570 38.9%   
Interest Rs m3835 108.0%   
Profit before tax Rs m1,5871,940 81.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718552 130.0%   
Profit after tax Rs m8691,387 62.7%  
Gross profit margin %24.215.4 156.9%  
Effective tax rate %45.228.5 158.8%   
Net profit margin %13.19.8 133.5%  
BALANCE SHEET DATA
Current assets Rs m6,23210,470 59.5%   
Current liabilities Rs m1,4902,749 54.2%   
Net working cap to sales %71.554.6 130.8%  
Current ratio x4.23.8 109.8%  
Inventory Days Days8655 156.6%  
Debtors Days Days8378 106.4%  
Net fixed assets Rs m4,0435,811 69.6%   
Share capital Rs m127167 76.2%   
"Free" reserves Rs m8,18314,248 57.4%   
Net worth Rs m8,31014,416 57.6%   
Long term debt Rs m180-   
Total assets Rs m10,38917,649 58.9%  
Interest coverage x43.156.6 76.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.8 79.7%   
Return on assets %8.78.1 108.4%  
Return on equity %10.59.6 108.7%  
Return on capital %19.513.7 142.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,6226,164 91.2%   
Fx outflow Rs m1,7991,334 134.8%   
Net fx Rs m3,8224,829 79.1%   
CASH FLOW
From Operations Rs m3561,231 28.9%  
From Investments Rs m-279-208 133.9%  
From Financial Activity Rs m-225-595 37.8%  
Net Cashflow Rs m-148427 -34.7%  

Share Holding

Indian Promoters % 63.4 55.4 114.4%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 0.0 3.4 -  
FIIs % 0.0 3.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 37.0 98.6%  
Shareholders   37,287 30,437 122.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   WOCKHARDT  FULFORD INDIA  PROCTER & GAMBLE HEALTH  DIVIS LABORATORIES  UNICHEM LAB  

Compare SUVEN LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


Apr 16, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS